Skip to content

Search

Search icon

In-centre haemodialysis at Newcastle upon Tyne Hospitals

In June 2019, Newcastle upon Tyne Hospitals NHS Foundation Trust (NUTH) became the first healthcare organisation in the world to declare a Climate Emergency,  recognising that a climate emergency is also a health emergency, and committed to becoming a net-zero carbon organisation by 2040. In response, the Green Nephrology Group at NUTH developed a roadmap with Continue reading “In-centre haemodialysis at Newcastle upon Tyne Hospitals”

Environmental impacts of poor control and improved control of paediatric asthma by use of intelligent digitally-connected Dry Powdered Inhalers (DPI)

The use of digital technology in asthma treatment is relatively new and is still evolving. It promises to revolutionise the management of the disease. The Sustainable Healthcare Coalition has worked with member company AstraZeneca to produce a study that demonstrates that good asthma treatments, effectively delivered and adhered to, result in reduced environmental impacts.

Environmental Impact of PlGF-based testing for pre-eclampsia

The availability of quick, accurate blood tests that can help rule out pre-eclampsia (PE) is improving care for pregnant women and their unborn babies, reducing anxiety and saving the NHS money. The Oxford Academic Science Network, who have been championing the use of PlGF-based testing, have worked with the Sustainable Healthcare Coalition to appraise the Continue reading “Environmental Impact of PlGF-based testing for pre-eclampsia”

Environmental Impact and Benefits of Care4Today Total Knee Replacement Care Pathway

Environmental Impact and Benefits of Care4Today Total Knee Replacement Care Pathway This new case study from Johnson & Johnson demonstrates the value of assessing care pathways with an environmental impact lens. It reinforces value-based healthcare, in that improved health outcomes following knee replacement surgery using Care4Today®, a digital care pathway programme, correlate with a reduced Continue reading “Environmental Impact and Benefits of Care4Today Total Knee Replacement Care Pathway”

Care pathway for Monoclonal Antibody Therapy

Care pathway for Monoclonal Antibody Therapy of Severe Eosinophilic Asthma The use of Monoclonal Antibody (Mab) therapy is relatively new and evolving, but promises to revolutionise the management of asthma. This study by AstraZeneca has demonstrated the value of appraising the sustainability of care pathways using SHC’s guidance. The assessment has identified the environmental hotspots Continue reading “Care pathway for Monoclonal Antibody Therapy”

Want to join an event or get involved?

Get in touch

Follow us